OTC Village: A "Facebook" for Over-the-Counter Bulletin Board Companies
-
Font Size:
The founders, Jeff Corbin and Todd Fromer, certainly know the investor relations field. They run KCSA, a worldwide investor relations firm based in New York. It does not take the intellect of a rocket scientist to realize that one of the primary impediments to cogent communications with shareholders for an OTC/BB company is budgetary. OTC/BB companies rarely can justify the expenditures to hire consultants for the usual full-court press offered by investor relations consultants. National exchanges often provide considerable assistance in helping listed companies with programs to “meet and greet” investors, but OTC/BB companies get very little outside assistance.
OTC Village is intended to fill the void at an affordable price. The web site offers a tutorial on how to use the portal as well as investor relations tips and best practices guidelines. It is possible for the company to link directly to the OTC Village from the corporate web site. Of course, the social networking sites for people like MySpace and Facebook have worked because they have visitor traffic. OTC Village has set up a page for visitors called "My OTC Village". Interested parties can look up information about companies, sign up for e-mail alerts and chat with other investors on message boards. The verdict is still out on whether OTC Village will be able to screen out chat room visits by those who use misinformation to influence trading. We note that "My OTC Village" requires a registration questionnaire, but it asks very little information. OTC Village has just swung its doors open to the world so I imagine there are a few kinks to work out in the program.
OTC Village has its first converts - NeoStem, Inc. (NEOI.OB) and Opthalmic Imaging System (OISI.OB). Both companies are still at early stages of development, have complex and innovative business operations and limited resources to get their message out to shareholders and investors.
Based in New York City, NeoStem operates an adult stem cell bank. Deposited cells are used for autologous or personal use. Customers include adults who wish to have their stem cells collected and banked for future therapeutic use against such diseases as diabetes, heart disease and cancer. Stem cells are thought to have regenerative therapies for wound healing and immune system fortification. NeoStem has no revenue so far and is still operating at a loss. At the end of September 2006, it had $1.3 million in cash in the bank and operations are burning about $1.0 million per quarter. A good share of spending is for business development, branding and public relations efforts.
Ophthalmic Imaging System has a little larger nest egg of $5.9 million in cash and equivalents. The company also generated cash so far this year - $1.6 million in the first nine months of 2006 - principally from $1.6 million earnings on $6.4 million in sales during that same period. The company has $5.9 million in cash in the bank. OIS’s business of designing and marketing digital imaging systems and software has ready demand among physicians in the ocular health field. Since OIS is targeting an easily identifiable customer base, the cost of customer acquisition is modest. Consequently, the operating profit margin is near 14%.
Both NeoStem and OIS need to cultivate awareness and support among a variety of constituents, customers, partners, shareholders, and new investors alike. While the messages to each constituency may be slightly different none are delivered in private and every message has meaning for bystanders. Thus the corporate exposure for each company on OTC Village contributes to awareness for investors as well as other "stakeholders.” This could be good bargain for small companies with big dreams.
Disclosure: Author has no position in above-mentioned stocks nor any affiliation with OTC Village.
- Immtech Pharmaceuticals, Inc. F1Q09 (Qtr End 06/30/08) Earnings Call Transcript »
- Five Biopharma Companies Drop on Negative Drug News »
- Amylin, Lilly: Another Case of a Panic Driven Sell-Off »
- Drug Safety Updates For Elan, Biogen, Amylin, and Lilly »
- Amylin Shares Gain Ground on Outlook for Byetta »
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Report from the Bond War Frontlines
- GDP and the Decline of National Statistics
- Commodities and Emerging Markets: Joined at the Hip?
- On Recent Financial Stories
- Five Good ETF Ideas That Have Yet to Catch On
- Fannie/Freddie Rally: A Product of Fed Intervention
- Full list of Editor's Picks »
- Has Jim Cramer Crossed the Line with Sirius XM? »
- Grab Your Shorts, the Tide Has Turned »
- Looming Financial Catastrophe: A Real Inconvenient Truth »
- Apple's Biggest Rumor: iPod or Jobs? »
- Wall Street Breakfast: Must-Know News »
- Wall Street Breakfast: Must-Know News »
- Wall Street Breakfast: Must-Know News »
- Buffett Takes Berkshire Hathaway on $4 Billion Spending Spree »
- Sirius XM Shorts Scrambling to Cover »
- AIG and the Lunacy of GAAP Reporting »
- Solarfun Power Holdings Co., Ltd. Q2 2008 Earnings Call Transcript »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Natural Gas Is Oversold, and We Are Buying
- Libbey Inc.: The Glass is Half Full
- Mad Money Manual - Cramer's Mad Money (8/28/08)
- An Eye on Gustav - Fast Money Recap (8/28/08)
- Will You Look Back on Today as Your Greatest Missed Opportunity?
- Hedge Fund Manager's Notebook: Why Hummers Are Greener Than Hybrids, and Tech & Homebuilders May Be a Buy
- News Pitch: Why To Buy News Corp
- Is This the Death of Gold & Silver Stocks? Part II
- Pacific Ethanol: Market Growth and Increase in Production to the Rescue
- Office Depot vs. Staples: Discounted Book vs. Superior ROE
- Full list of Long Ideas »
- The Option Arm Triplets: Dead Banks Walking
- Short Thesis Still Intact at FirstFed
- Short Story: Lehman
- 'Buy, But Sell' - What Are Analysts Thinking?
- Nordson's Rally Is Over, For Now - Barron's
- What's So Special About RadioShack? - Barron's
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Commodity Carnage: Where to Turn Next?
- Full list of Short Ideas »
- Mad Money Manual - Cramer's Mad Money (8/28/08)
- Diversified Portfolios - Cramer's Mad Money (8/27/08)
- Gustav Moves Overdone - Cramer's Stop Trading! (8/27/08)
- GrafTech is Too Cheap - Cramer's Stop Trading
- The Rebound List - Cramer's Mad Money (8/26/08)
- The List - Cramer's Stop Trading! (8/26/08)
- Can't Turn My Back - Cramer's Lightning Round (8/26/08)
- The Pelosi Factor - Cramer's Mad Money (8/25/08)
- Buy Tech Weakness - Cramer's Lightning Round (8/25/08)
- Fannie & Freddie Too Difficult - Cramer's Stop Trading! (8/25/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »



This article has 1 comment:
Jackson
Sounds like you'll get a lot of spam email if you give these guys your email address, no?